Drug intelligence / Profile preview

Sangustop

Development stage
Unknown
Lead developer
B. Braun Aesculap
Administration
Topical
01

Overview

Sangustop is a **topical haemostatic agent** composed of **native absorbable collagen fibrils** designed for local haemostasis of capillary bleeding and bleeding in parenchymal organs, particularly during surgical procedures such as liver resection[1][7]. It does not contain any coagulation factors, blood serum products, or pharmaceutically active plasma components. Sangustop functions by providing a felt structure rich in surface area that facilitates the adhesion of blood platelets, thereby accelerating clot formation and haemostasis. Its mechanism is strictly physical—based on collagen-induced platelet aggregation—rather than pharmacological action. Sangustop is manufactured under the Aesculap brand, part of B. Braun, and is indicated for local haemostasis, especially in situations of diffuse oozing hemorrhage or as a supportive measure for other haemostatic techniques[1][2][3][4][5]. Preclinical and clinical studies have demonstrated rapid and reliable haemostatic efficacy, making it suitable in liver and other parenchymal organ surgeries[1][7].

Brand names
Sangustop
Other names
Sangustop

Beyond the preview

Go deeper on Sangustop.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sangustop.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call